Rune Blomhoff
Corporate Officer/Principal presso University of Oslo
Profilo
Rune Blomhoff was the founder of Cgene AS, where he held the title of Chairman in 1985.
Currently, he holds the position of Professor at the University of Oslo.
Posizioni attive di Rune Blomhoff
| Società | Posizione | Inizio |
|---|---|---|
| University of Oslo | Corporate Officer/Principal | - |
Precedenti posizioni note di Rune Blomhoff
| Società | Posizione | Fine |
|---|---|---|
Cgene AS
 Cgene AS Miscellaneous Commercial ServicesCommercial Services Cgene AS is a holding company that offers contract-based research within the field of in vivo molecular imaging. It is a biotechnology company that has available mice models designed to report real-time gene activity in a living animal, reflecting normal or pathological molecular processes in conditions such as inflammation, infection, oxidative stress, cancer, and cardiovascular disease, hypoxia, and retinoid effects. It develops and makes commercially available new reporter models for in vivo molecular imaging purposes. It also tailors transgenic models to meet specific customer needs. Its reporter models serve as preclinical tool for cost-efficient drug screening by pharmaceutical companies. The company was founded by Harald Carlsen and Rune Blomhoff on April 22, 1985 and is headquartered in Oslo, Norway. | Fondatore | - |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 1 |
|---|---|
Cgene AS
Cgene AS Miscellaneous Commercial ServicesCommercial Services Cgene AS is a holding company that offers contract-based research within the field of in vivo molecular imaging. It is a biotechnology company that has available mice models designed to report real-time gene activity in a living animal, reflecting normal or pathological molecular processes in conditions such as inflammation, infection, oxidative stress, cancer, and cardiovascular disease, hypoxia, and retinoid effects. It develops and makes commercially available new reporter models for in vivo molecular imaging purposes. It also tailors transgenic models to meet specific customer needs. Its reporter models serve as preclinical tool for cost-efficient drug screening by pharmaceutical companies. The company was founded by Harald Carlsen and Rune Blomhoff on April 22, 1985 and is headquartered in Oslo, Norway. | Commercial Services |
- Borsa valori
- Insiders
- Rune Blomhoff
